TARDBP and supranuclear palsy, progressive, 1: The higher prevalence of TDP-43 pathology in the amygdala in PSP-F compared with PSP-PF (19.2% vs. 3.2%, P < 0.05; Table 1) suggests a potential contribution of TDP-43 pathology to the clinical heterogeneity of PSP.